Emanuel: We are positive on healthcare

FromBloomberg Surveillance

Start listening View podcast show

Emanuel: We are positive on healthcare

FromBloomberg Surveillance

ratings:

Length:

20 minutes

Released:

Apr 28, 2016

Format:

Podcast episode

Description

UBS's Julian Emanuel weighs in on the healthcare sector after Abbott Laboratories announced plans to buy St. Jude Medical for about $25 billion on Bloomberg Surveillance with Michael McKee and David Gura.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Released:

Apr 28, 2016

Format:

Podcast episode

Titles in the series (100)

Tom Keene, Jon Ferro, Lisa Abramowicz, and Paul Sweeney have the economy and the markets "under surveillance" as they cover the latest in finance, economics and investment, and talk with the leading voices shaping the conversation around world markets.

Skip carousel

Colas: VIX starts to get interesting at 40: Colas: VIX starts to get interesting at 40 by Bloomberg Surveillance
12 min listen
Mather: Greater degree of uncertainty creating choppy markets: Mather: Greater degree of uncertainty creating choppy markets by Bloomberg Surveillance
11 min listen
Bloomberg Surveillance: Glassman and Gross: Bloomberg Surveillance: Glassman and Gross by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Ross, Abramowicz & White: Bloomberg Surveillance: Ross, Abramowicz & White by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Ricchiuto & Newport: Bloomberg Surveillance: Ricchiuto & Newport by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Sinche and Chandler on Currencies: Bloomberg Surveillance: Sinche and Chandler on Currencies by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Emons, Wheeler & Paulsen: Bloomberg Surveillance: Emons, Wheeler & Paulsen by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Lee on IMF reforms: Bloomberg Surveillance: Lee on IMF reforms by Bloomberg Surveillance
8 min listen
8am-9am ET: Sowerby, Tisch & Rupkey: 8am-9am ET: Sowerby, Tisch & Rupkey by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Feb. 18, 2016: 9am-10am ET: Marks, Patel, Hayes & Elliot by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Cohen & Dequadros: Bloomberg Surveillance: Cohen & Dequadros by Bloomberg Surveillance
43 min listen
Hegarty: uptrend in shelter part of CPI: Hegarty: uptrend in shelter part of CPI by Bloomberg Surveillance
12 min listen
7am-8am ET: Curnutt, Nocera, Strauss & Sorrell: 7am-8am ET: Curnutt, Nocera, Strauss & Sorrell by Bloomberg Surveillance
43 min listen
Ghahramani: Saudi policy shift is subtle but important: Ghahramani: Saudi policy shift is subtle but important by Bloomberg Surveillance
11 min listen
Caron: interest rates not the best solution: Caron: interest rates not the best solution by Bloomberg Surveillance
12 min listen
Marks: A good opportunity in distressed bonds: Marks: A good opportunity in distressed bonds by Bloomberg Surveillance
12 min listen
Bloomberg Surveillance: Weinberg, Rose, Stockton & Todd: Bloomberg Surveillance: Weinberg, Rose, Stockton & Todd by Bloomberg Surveillance
43 min listen
Bloomberg Surveillance: Cantrill, Levitt, Steel & Elliot: Bloomberg Surveillance: Cantrill, Levitt, Steel & Elliot by Bloomberg Surveillance
43 min listen
Levitt: regulators should be nervous with credibility at risk: Levitt: regulators should be nervous with credibility at risk by Bloomberg Surveillance
8 min listen
Bloomberg Surveillance: Foley, Major & Levy: Bloomberg Surveillance: Foley, Major & Levy by Bloomberg Surveillance
43 min listen
Shilling: deflation from Japan concerning central banks: Shilling: deflation from Japan concerning central banks by Bloomberg Surveillance
8 min listen
Bloomberg Surveillance: Stovall, Piegza & Wheeler: Bloomberg Surveillance: Stovall, Piegza & Wheeler by Bloomberg Surveillance
43 min listen
Rupkey: eco data is strong, but consumers feel insecure: Rupkey: eco data is strong, but consumers feel insecure by Bloomberg Surveillance
11 min listen
Le: correlations are breaking down: Le: correlations are breaking down by Bloomberg Surveillance
11 min listen
7am-8am ET: Porter,: 7am-8am ET: Porter, Pettypiece & Le by Bloomberg Surveillance
43 min listen
Abramowicz: junk bond world has become toxic: Abramowicz: junk bond world has become toxic by Bloomberg Surveillance
11 min listen
Pettypiece: Wal-Mart taking time to turn around company: Pettypiece: Wal-Mart taking time to turn around company by Bloomberg Surveillance
11 min listen
8am-9am ET: Colas, Raines & Friedman: 8am-9am ET: Colas, Raines & Friedman by Bloomberg Surveillance
43 min listen
9am-10am ET: Kashkari, Abramowicz & Ghahramani: 9am-10am ET: Kashkari, Abramowicz & Ghahramani by Bloomberg Surveillance
43 min listen
PWC U.S. Energy Advisor Reid Morrison: PWC U.S. Energy Advisor Reid Morrison by Bloomberg Surveillance
11 min listen

More Episodes from Bloomberg Surveillance

Skip carousel

Inflation Implications by Bloomberg Surveillance
27 min listen
Bloomberg Surveillance TV: May 20, 2024 by Bloomberg Surveillance
35 min listen
Single Best Idea with Tom Keene: George Saravelos & Tracie McMillion by Bloomberg Surveillance
6 min listen
Bond Market Inflation Signals and Paramount Drama by Bloomberg Surveillance
30 min listen
Single Best Idea with Tom Keene: Lindsey Piegza & Tony Crescenzi by Bloomberg Surveillance
7 min listen
Bloomberg Surveillance TV: May 17, 2024 by Bloomberg Surveillance
25 min listen
Introducing: Big Take Asia by Bloomberg Surveillance
2 min listen
Single Best Idea with Tom Keene: Jamie Dimon & Constance Hunter by Bloomberg Surveillance
7 min listen
Bloomberg Surveillance TV: May 16, 2024 by Bloomberg Surveillance
32 min listen
Surveillance Special: Jamie Dimon on Inflation, China, Politics by Bloomberg Surveillance
16 min listen
Global Growth Outlook Post-CPI by Bloomberg Surveillance
31 min listen
Breaking Down CPI and Retail Sales in Key Eco Data Week by Bloomberg Surveillance
32 min listen
Bloomberg Surveillance TV: May 15, 2024 by Bloomberg Surveillance
26 min listen
Single Best Idea with Tom Keene: Paul Donovan & Meghan Graper by Bloomberg Surveillance
7 min listen
Single Best Idea with Tom Keene: Jeff Currie & Julian Emanuel by Bloomberg Surveillance
6 min listen
Bloomberg Surveillance TV: May 14, 2024 by Bloomberg Surveillance
29 min listen
PPI Reaction and Energy Outlook by Bloomberg Surveillance
32 min listen
Markets Await Inflation Data by Bloomberg Surveillance
30 min listen
Bloomberg Surveillance TV: May 13, 2024 by Bloomberg Surveillance
26 min listen
Single Best Idea with Tom Keene: John Ryding & Amanda Lynam by Bloomberg Surveillance
6 min listen
Bloomberg Surveillance TV: May 10, 2024 by Bloomberg Surveillance
25 min listen
Single Best Idea with Tom Keene: Jim Bianco & Craig Sterling by Bloomberg Surveillance
7 min listen
A Fed Rate Cut, Oil Slowdown, and Apple's AI Play by Bloomberg Surveillance
30 min listen
Bloomberg Surveillance TV: May 9, 2024 by Bloomberg Surveillance
24 min listen
Single Best Idea with Tom Keene: Matt Hornbach & Wendy Schiller by Bloomberg Surveillance
5 min listen
Investors Gearing for Inflation Data as US Issues Israel Warning by Bloomberg Surveillance
25 min listen
Equity Outlook and an iPhone and iPad Boost for Apple by Bloomberg Surveillance
35 min listen
Bloomberg Surveillance TV: May 8, 2024 by Bloomberg Surveillance
21 min listen
Single Best Idea with Tom Keene: Rich Clarida & Kona Haque by Bloomberg Surveillance
6 min listen
Bloomberg Surveillance TV: May 7, 2024 by Bloomberg Surveillance
36 min listen

Related podcast episodes

Skip carousel

The advantages of onsite manufacturing facilities for clinical trials by Conversations in Healthcare
36 min listen
Racing for a Vaccine: Moderna’s Phase 1 Human Trial: Moderna CEO Stephane Bancel shares the first human data for a Covid-19 vaccine program. Early results from the study are promising, and the markets agree. Surgeon, author, and The New Yorker staff writer Dr. Atul Gawande has a “Regimen for Reentry” as the United States plans reopening businesses in the wake of the pandemic. Plus, sagas from Silicon Valley: Grubhub spurns an Uber union, Softbank weathers a leadership and monetary loss, and Senator Amy Klobuchar (D-MN) is taking on big tech (again) via Twitter. by Squawk Pod
35 min listen
How shortening skilled nursing facility stays might identify waste in health care delivery: Listen to Health Affairs Editor-in-Chief Alan Weil interview J. Michael McWilliams about new research on skilled nursing facilities and taking costs out of the health care system. by A Health Podyssey
32 min listen
Episode 234 - H5N1 update - What to do about shows/exhibitions, USDA announces indemnity for lost production, CDC announces second case in humans - UMN Extension's The Moos Room by The Moos Room™
21 min listen
Pharma and Biotech Daily: Your Morning Dose of Industry Updates by Pharma and BioTech Daily
3 min listen
Finally, a new medicine for Alzheimer’s disease: One-on-one with Biogen’s Ivana Rubino by The BioWorld Insider Podcast
9 min listen
WISH 2022 - Antimicrobial resistance, and workforce wellbeing: Last month, saw the WISH ... by The BMJ Podcast
43 min listen
December 2nd, 2022 by The Top Line
16 min listen
Ep 952 | The Real Reason They Oppose Ivermectin? It Works and Vaccine Wanes by Conservative Review with Daniel Horowitz
51 min listen
Paul Tudor Jones: “Crypto is clearly winning”: Shares of Novavax are down sharply after Politico reported the company is having problems manufacturing its highly anticipated Covid-19 vaccine. Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, discusses Covid therapeutics, vaccines, and the U.S. production and manufacturing system. Paul Tudor Jones, founder and CIO at Tudor Investment Corporation and founder of the Robin Hood Foundation, shares his inflation trades and portfolio breakdown. The legendary hedge fund manager also explains which assets investors should stay away from as the Federal Reserve slowly reacts to rising prices. New York City has announced an expansion of its Covid vaccine mandate to all public employees, removing the option to test out. Plus, Facebook may soon be rebranded with a new name. In this episode: Dr. Scott Gottlieb, @ScottGottliebMD Paul Tudor Jones, @ptj_official Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin by Squawk Pod
40 min listen
Food Supply Disruptions and Nursing Home Industry Pushes for Immunity During Coronavirus by The Daily Dive
20 min listen
New antibiotic could help avert looming health crisis by FT News in Focus
7 min listen
Djokovic to play Australian Open with Medical Exemption | Three Ep. 70: Gill and Amy are joined by a doctor to discuss Novak Djokovic's medical exemption to play the Australian Open by Three — A Tennis Show
23 min listen
A Former Surgeon General on the Coronavirus Pandemic by Deep Background with Noah Feldman
36 min listen
Ep. 978 - Trans Radicals Make War In Kids’ Minds & Supply The Bullets: The “science” promoting puberty blockers for kids turns out to be funded by the pharmaceutical companies that make the puberty blockers for kids, the libs bring COVID back, and Yale calls Michael a threat to democracy ahead of his speech there with Ted Cruz next week. Order Andrew Klavan’s new book: The Truth and Beauty today: https://utm.io/uer2e . The magic has left the kingdom. It’s time to build new things that we can believe in. Subscribe to The Daily Wire today with promo code BUILDTHEFUTURE for 45% off: https://utm.io/uereW Learn more about your ad choices. Visit podcastchoices.com/adchoices by The Michael Knowles Show
49 min listen
Well, Now: Life After Lockdown: After four years and more than a million deaths, is America’s Covid crisis really over? by Slate News
41 min listen
Life After Lockdown: After four years and more than a million deaths, is America’s Covid crisis really over? by Well, Now
41 min listen
Well, Now: Life After Lockdown: After four years and more than a million deaths, is America’s Covid crisis really over? by Slate Culture
41 min listen
Well, Now: Life After Lockdown: After four years and more than a million deaths, is America’s Covid crisis really over? by Slate Daily Feed
41 min listen
Pharma and Biotech Daily: The Latest in Healthcare Innovation and Market Trends by Pharma and BioTech Daily
3 min listen
Episode 13 - Mold Illness, The Great Masquerader with Dr. Andrew Campbell by Exposing Mold
50 min listen
The Future of Liberty, Medicine, Free Speech by Rich Dad Radio Show: In-Your-Face Advice on Investing, Personal Finance, & Starting a Business
34 min listen
Study Shows That COVID-19 Patients Testing Positive After Recovering Are Not Infectious by The Daily Dive
20 min listen
Steve Kirsch on mRNA Spike Protein, VAERS Data & Sudden Deaths w/ Dr. Kelly Victory – Ask Dr. Drew – Episode 161: Steve founded and sold multiple billion-dollar tech companies, including 1990's search engine Infoseek and Frame Technology Group. by Ask Dr. Drew
98 min listen
Why is England keeping the abortion ‘pills by post’ scheme?: Last week MPs voted to keep the ‘pills by post’ abortion service introduced at the start of the Covid-19 pandemic. Madeleine Finlay finds out about the benefits of self-managed medical abortions and whether ‘Plan C’ could ever become available from pharmacies by Science Weekly
15 min listen
One Year into Covid: Pfizer CEO on Vaccine Efficacy: It’s been a year since the World Health Organization officially declared Covid-19 a pandemic on March, 11, 2020. In that time, there have been more than 29 million Covid cases in the U.S. and 527,720 people have died. Today, Pfizer said its Covid-19 vaccine blocked 94% of asymptomatic infections in an Israeli study – a result CEO Albert Bourla called “extremely important.” The study also found the vaccine was at least 97% effective against symptomatic Covid cases, hospitalizations and deaths. Plus, Becky and Joe’s pandemic recipes and Andrew’s favorite workout. by Squawk Pod
26 min listen
I can't believe it's not breastmilk by Today, Explained
22 min listen
Pharma and Biotech Daily: Insights on FDA Approvals, Drug Performance, and Health Advertising Strategies by Pharma and BioTech Daily
2 min listen
Governor Newsom Proposes Expanded Healthcare Coverage for Californians by KQED's The California Report
16 min listen
Witty words on data: Andrew Witty is the CEO of GlaxoSmithKline. He’s been credited with taking on a pharma company with a history of behaving badly in the past – as shown by a record $3bn fine levied by the US government last year. How much is he able or willing to chan... by The BMJ Podcast
19 min listen

Discover this podcast and so much more

Emanuel: We are positive on healthcare

Emanuel: We are positive on healthcare

Description

Titles in the series (100)

More Episodes from Bloomberg Surveillance

Related podcast episodes